Jingsong Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jingsong Chen has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Huiting Tan
Department of Endocrinology, The First People’s Hospital of Foshan, 528000 Foshan, Guangdong, China
2 shared publications - Xuejuan Xu
Department of Endocrinology, The First People's Hospital of Foshan, Foshan 528000, China
2 shared publications - Cuiying Mo
Department of Endocrinology, The First People’s Hospital of Foshan, Foshan, Guangdong 528000, China
1 shared publication - Guoqiang Chen
Department of Rheumatology, First People's Hospital of Foshan, China; Department of Rheumatology, Second People's Hospital of Foshan, China
1 shared publication - Jie Shen
The Eighth Affiliated Hospital, Southern Medical University (The First People’s Hospital of Shunde, Foshan), China
1 shared publication - Leshan Chen
The First Clinical Medical College of Guangdong Medical University, 524000 Zhanjiang, Guangdong, China
1 shared publication
Latest Publications
- Open Access
- 30 May 2025
- Published by IMR Press in Frontiers in Bioscience-Landmark
- Vol. 30 (6) , 36204
Gut Microbiota in Primary Sarcopenia: Mechanisms and Potential Therapeutic Targets
As the global population ages, the risks associated with primary sarcopenia, including falls, fractures, functional decline, and frailty, are becoming increasingly apparent, all of which significantly impair the quality of life in older adults. Emerging evidence suggests that the gut microbiota plays a pivotal role in maintaining muscle physiology. Specific gut bacteria promote intramuscular protein synthesis through the production of certain amino acids (e.g., leucine, tryptophan), short-chain fatty acids (SCFAs), and hydrogen sulfide. Notably, Escherichia coli expressing the enzyme nicotinamidase (PncA) has been shown to enhance nicotinamide adenine dinucleotide (NAD+) synthesis, potentially improving mitochondrial function in muscle tissue. Furthermore, secondary bile acids and lactate influence the levels of fibroblast growth factor 15/19 and unacylated ghrelin in circulation by binding to receptors that are highly expressed in gut endocrine cells, thereby affecting muscle physiology. This review examines the characteristic composition of the gut microbiota in patients with sarcopenia, its role in primary sarcopenia, and potential therapeutic targets.
- 30 May 2025
- Published by IMR Press in Frontiers in Bioscience-Landmark
- Vol. 30 (6) , 36204
Open AccessGut Microbiota in Primary Sarcopenia: Mechanisms and Potential Therapeutic Targets
As the global population ages, the risks associated with primary sarcopenia, including falls, fractures, functional decline, and frailty, are becoming increasingly apparent, all of which significantly impair the quality of life in older adults. Emerging evidence suggests that the gut microbiota plays a pivotal role in maintaining muscle physiology. Specific gut bacteria promote intramuscular protein synthesis through the production of certain amino acids (e.g., leucine, tryptophan), short-chain fatty acids (SCFAs), and hydrogen sulfide. Notably, Escherichia coli expressing the enzyme nicotinamidase (PncA) has been shown to enhance nicotinamide adenine dinucleotide (NAD+) synthesis, potentially improving mitochondrial function in muscle tissue. Furthermore, secondary bile acids and lactate influence the levels of fibroblast growth factor 15/19 and unacylated ghrelin in circulation by binding to receptors that are highly expressed in gut endocrine cells, thereby affecting muscle physiology. This review examines the characteristic composition of the gut microbiota in patients with sarcopenia, its role in primary sarcopenia, and potential therapeutic targets.
- RetractedOpen Access
- 15 September 2022
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2022 (1) , 9774570
[Retracted] Exploring the Temporal Correlation of Sarcopenia with Bone Mineral Density and the Effects of Osteoblast‐Derived Exosomes on Myoblasts through an Oxidative Stress–Related Gene
Sarcopenia is an age‐related accelerated loss of muscle strength and mass. Bone and muscle are closely related as they are physically adjacent, and bone can influence muscle. However, the temporal association between bone mineral density (BMD) and muscle mass in different regions of the body after adjustment for potential indicators and the mechanisms by which bone influences muscle in sarcopenia remain unclear. Therefore, this study aimed to explore the temporal association between muscle mass and BMD in different regions of the body and mechanisms by which bone regulates muscle in sarcopenia. Here, cross‐lagged models were utilized to analyze the temporal association between BMD and muscle mass. We found that low‐density lipoprotein (LDL‐C) positively predicted appendicular lean mass. Mean whole‐body BMD (WBTOT BMD), lumbar spine BMD (LS BMD), and pelvic BMD (PELV BMD) temporally and positively predicted appendicular lean mass, and appendicular lean mass temporally and positively predicted WBTOT BMD, LS BMD, and PELV BMD. Moreover, this study revealed that primary mice femur osteoblasts, but not primary mice skull osteoblasts, induced differentiation of C2C12 myoblasts through exosomes. Furthermore, the level of long noncoding RNA (lncRNA) taurine upregulated 1 (TUG1) was decreased, and the level of lncRNA differentiation antagonizing nonprotein coding RNA (DANCR) was increased in skull osteoblast–derived exosomes, the opposite of femur osteoblast–secreted exosomes. In addition, lncRNA TUG1 enhanced and lncRNA DANCR suppressed the differentiation of myoblasts through regulating the transcription of oxidative stress–related myogenin (Myog) gene by modifying the binding of myogenic factor 5 (Myf5) to the Myog gene promoter via affecting the nuclear translocation of Myf5. The results of the present study may provide novel diagnostic biomarkers and therapeutic targets for sarcopenia.
- 15 September 2022
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2022 (1) , 9774570
RetractedOpen Access[Retracted] Exploring the Temporal Correlation of Sarcopenia with Bone Mineral Density and the Effects of Osteoblast‐Derived Exosomes on Myoblasts through an Oxidative Stress–Related Gene
Sarcopenia is an age‐related accelerated loss of muscle strength and mass. Bone and muscle are closely related as they are physically adjacent, and bone can influence muscle. However, the temporal association between bone mineral density (BMD) and muscle mass in different regions of the body after adjustment for potential indicators and the mechanisms by which bone influences muscle in sarcopenia remain unclear. Therefore, this study aimed to explore the temporal association between muscle mass and BMD in different regions of the body and mechanisms by which bone regulates muscle in sarcopenia. Here, cross‐lagged models were utilized to analyze the temporal association between BMD and muscle mass. We found that low‐density lipoprotein (LDL‐C) positively predicted appendicular lean mass. Mean whole‐body BMD (WBTOT BMD), lumbar spine BMD (LS BMD), and pelvic BMD (PELV BMD) temporally and positively predicted appendicular lean mass, and appendicular lean mass temporally and positively predicted WBTOT BMD, LS BMD, and PELV BMD. Moreover, this study revealed that primary mice femur osteoblasts, but not primary mice skull osteoblasts, induced differentiation of C2C12 myoblasts through exosomes. Furthermore, the level of long noncoding RNA (lncRNA) taurine upregulated 1 (TUG1) was decreased, and the level of lncRNA differentiation antagonizing nonprotein coding RNA (DANCR) was increased in skull osteoblast–derived exosomes, the opposite of femur osteoblast–secreted exosomes. In addition, lncRNA TUG1 enhanced and lncRNA DANCR suppressed the differentiation of myoblasts through regulating the transcription of oxidative stress–related myogenin (Myog) gene by modifying the binding of myogenic factor 5 (Myf5) to the Myog gene promoter via affecting the nuclear translocation of Myf5. The results of the present study may provide novel diagnostic biomarkers and therapeutic targets for sarcopenia.